Affluent Medical strengthens its executive team

Michel Finance is appointed CEO.
Executive team is strengthened with the appointment of:
Daniele Zanotti (the former CEO) as Chief Technology and Innovation Officer leading technology developments and the execution of programs,
Professor Fran├žois Laborde as Chief Clinical and Scientific Affairs Officer,
Marianna Luppi as Regulatory Affairs Director,
Brian Burg as Cardiovascular Program Director.